Providing corporate advisory services and capital to companies with an entrepreneurial flair that are either listed or preparing to list on the ASX
We firmly believe in the transformative power of innovation, and endeavor to launch new projects with the power to disrupt established industries and to bring novel concepts to untapped markets.
We provide strategic advisory, capital markets and business development services to our clients, as one of the few institutional grade corporate advisors specialising in concept and frontier technology companies on the ASX.
We invest in startups and business ventures that endeavour to solve global problems through innovation. We incubate and launch our own start-up initiatives across an array of industries in collaboration with world class researchers.
We specialise in early stage, concept and frontier technology companies. Our ‘funds management’ roots give you access to a truly unique perspective into an investor’s mind.
Assistance with capital raisings, fixed interest offers, takeovers and strategic reviews
We assist private companies looking to fund growth plans through private equity and capital raisings
We help take your idea to market the right way. We are not just advisors… we can also be investors through Cadmon Ventures
We assist vendors to maximise valuation through optimal deal structuring
Our extensive partnership and vendor network means we see over 600 opportunities a year. Talk to us to see how we can help
We provide expert advice on takeover defence, mergers and acquisitions
From new product launches and the expansion of existing business lines, to the development of greenfield projects and market pivots, we help our clients make the right decisions for their business. We provide bespoke solutions and the level of close client attention of a boutique firm, with a partner always present for all projects.
Entrepreneurship is at the heart of our company, and imbues all of the work we do.
We seek early stage companies in whose team, product and business model we believe and whose future we can help shape. We are not afraid to make bold bets.
We have key areas of interest for future investments – such as clean-tech, med-tech and agri-tech – but historically our approach has been largely industry-agnostic.
What we look for above all else is an attractive, scalable business opportunity that addresses a market disparity in a novel way (preferably with strong IP protection), with an executive team that we believe in, and can trust to deliver.
We are a team of businessmen and investors from various professional disciplines who develop investment opportunities across several industries, with local and foreign partners.
Before starting Cadmon, Cameron spent years working at companies such as Acorn Capital, UniSuper and Deloitte in the areas of funds management, equity and quantitative research and financial modelling. Cameron holds a Bachelors in Commerce/Science and Masters in Applied Finance both from Monash University.
Prior to Cadmon, Pat worked at Acorn Capital as an Investment Analyst covering the Financials and REITs sector. Before Acorn, Pat was at CLSA - Asia's leading and longest-running independent brokerage and investment group. At CLSA, she was the primary analyst for 3 sectors in Thailand including Consumer, Telecommunication, and Media and was voted to the No.1 analyst from Asiamoney Broker Poll in Food & Staple Retailing Sector (2010, 2012, 2013, and 2014), Food, Beverage & Tobacco Sector (2013 and 2014), and Media Sector (2013 and 2014). Pat has a Bachelor of Business Administration - Finance degree (First Class Honors) from Thammasat University.
Prior to Cadmon, Lily was a corporate lawyer at Herbert Smith Freehills where she worked on a range of public and private M&A transactions, initial public offerings, capital raisings, privatisation and infrastructure projects, corporate restructures and provided general corporate advice to clients across multiple industries. Lily holds a Bachelor of Laws (1st Class Hons) and Bachelor of Commerce from Monash University.
Senior Corporate Analyst
Prior to Cadmon, Ben was an Analyst at Blue Sky Alternative Investments Limited (ASX:BLA) where he worked within the operations, distribution and alternative access fund (ASX:BAF) teams. This gave him exposure to a broad range of alternative asset classes including Private Equity, Venture Capital, Real Assets, Private Real Estate and Hedge Funds. Ben is also currently completing a Bachelor of Business majoring in banking and finance with minors accounting and business statistics at Monash University.
Our advisors come from a diverse range of industries and professional backgrounds. They are innovators and thought leaders in their fields who bring strong ideas and a global mindset to the table. Their vast network, broad experience and valuable insights bolster our collective success.
Dr Altay Altuntas
Orthopaedics | Medical Devices | Biotech
Dr Alturas is an internationally recognised Orthopaedic Surgeon. He adopts a holistic approach and is continually aware of new and innovative treatment styles. He has public hospital appointments at St Vincent's Hospital and the Northern Hospital and is a lecturer at the University of Melbourne and a former Senior Clinical Lecturer at Imperial College London.
Green Tech | Environments
Bert has over 25 years of experience in mining, mineral processing and infrastructure development including most recently senior roles with Perth Airport and BHP Billiton Iron Ore. He serves as Research and Technology Development Manager at Keshi Technologies, a company involved in developing next generation clean-tech solutions. He is also a Honorary Research Fellow at the University of Western Australia.
Dr Michael Green
Resources | Energy
Dr Green is a geologist with over 15 years’ experience with managing all aspects of exploration programs in Australia and around the world, targeting a broad range of commodities with a focus on base and precious metals. He has also served senior executive positions on a number of ASX listed resource companies. He completed his PhD at the University of Sydney and undergraduate degree from the University of Western Australia.
Pharmaceuticals | Biochemistry
Steven is experienced in pharmacology & biochemistry. He is a commercial pharmacist and pharmacy owner. He has a strong track record in providing high net worth clients, publicly listed and private biotech companies with technical consultancy services. He is also a successful Biotechnology investor, with specific areas of interest in neuro-pharmacology and cardiovascular disease. Steven is a Melbourne University and Latrobe University graduate in the fields of Pharmacology and Biochemistry.